PepGen (PEPG) Other Accumulated Expenses (2021 - 2026)

PepGen (PEPG) reported Other Accumulated Expenses of $2.4 million for Q1 2026, down 78.75% on a YoY basis from $11.5 million in Q1 2025, and up 1105.94% sequentially from $202000.0 in Q4 2025.

PepGen (PEPG) Other Accumulated Expenses (2021 - 2026) Analysis & Trends

PepGen (PEPG) has 6 years of Other Accumulated Expenses data on file, last reported at $2.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Accumulated Expenses fell 78.75% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (down 78.75% YoY), and the FY2025 full-year result was $202000.0, down 97.07% from the prior year.
  • Other Accumulated Expenses improved to $2.4 million in Q1 2026, from $202000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $11.5 million in Q1 2025 to a low of $202000.0 in Q4 2025.
  • A 5-year average of $3.2 million and a median of $1.6 million in 2022 frame the typical range for Other Accumulated Expenses.
  • Peak annual rise in Other Accumulated Expenses reached 1103.99% in 2025, while the deepest fall reached 97.07% in 2025.
  • Tracing PEPG's Other Accumulated Expenses over 5 years: stood at $1.1 million in 2022, then declined by 18.54% to $918000.0 in 2023, then surged by 651.96% to $6.9 million in 2024, then plunged by 97.07% to $202000.0 in 2025, then surged by 1105.94% to $2.4 million in 2026.
  • Business Quant data shows PEPG's Other Accumulated Expenses at $2.4 million in Q1 2026, $202000.0 in Q4 2025, and $476000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 PepGen 145.09 Mn 145.09 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 2.44 Mn
Dec 31, 2025 202,000.00
Sep 30, 2025 476,000.00
Jun 30, 2025 8.90 Mn
Mar 31, 2025 11.46 Mn
Dec 31, 2024 6.90 Mn
Sep 30, 2024 2.68 Mn
Jun 30, 2024 944,000.00
Mar 31, 2024 952,000.00
Dec 31, 2023 918,000.00
Sep 30, 2023 10.27 Mn
Jun 30, 2023 1.14 Mn
Mar 31, 2023 1.87 Mn
Dec 31, 2022 1.13 Mn
Sep 30, 2022 918,000.00
Jun 30, 2022 1.62 Mn
Mar 31, 2022 1.56 Mn
Dec 31, 2021 533,000.00